Aurinia Pharmaceuticals Inc (AUPH)

Operating Cash Flow Growth

87.47%

TTM · Period ending:

AUPH logo

AUPH Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported87.47%
AUPH TTM Cash from Operations YoY % (-324.52% → 87.47%)
High-resolution chart · PNG

AUPH operating cash flow growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Aurinia Pharmaceuticals Inc Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
87.4653%
157.9428%
203.1475%
320.1497%
5,488.6047%
415.2975%
232.6559%
176.5908%
95.6354%
68.3661%
57.926%
67.7975%
72.0092%
57.2868%
49.5669%
8.243%
-22.9824%
-52.2766%
-131.3522%
-27.6676%
-39.103%
-35.8252%
-7.3435%
-91.0351%
-60.2906%
-44.8163%
-23.0343%
-5.5301%
-10.9519%
-9.9162%
-25.3613%
-42.8817%
-54.1935%
-97.4922%
-120.0021%
-78.0519%
-47.8302%
-22.4503%
-5.3957%
-18.6335%
-34.5596%
-21.7042%
-5.0281%
-1.546%
-11.8863%
-61.0129%
-274.2188%
-463.0637%
-452.3175%
-100.7144%
29.7487%
58.7421%
65.1941%
16.3194%
-374.3783%
-188.3483%
-481.316%
-169.5986%
68.7543%
32.4612%
76.1015%
68.8477%
58.5109%
65.9208%
53.1806%
35.8041%
39.8717%
53.2094%
63.6111%
66.9637%
38.8958%
19.4869%
-29.9997%
-56.6696%
-35.3284%
-32.1229%
-16.191%
1.0522%
0.9422%
10.4784%
22.9519%
13.1706%
-5.358%
-66.7527%
-109.6557%
-404.3222%
-292.4731%
-84.7761%
-4,682.6264%
-114.9247%
-504.1077%
-339.9949%
107.2493%
68.126%
145.1025%
59.0449%
7.3776%
-56.7251%
-195.9987%
-197.0093%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.